A drug developed to treat multiple sclerosis may prove to be an effective treatment for one of the most common causes of blindness. A team from the Weizmann Institute of Science in Israel used the drug to block loss of eyesight in animals with a disease resembling the human condition glaucoma. The finding suggests that the drug, Copaxone, may also stop, or at least slow down, the loss of eyesight in people who have a chronic form of the disease.

Full Story from BBC News: http://news.bbc.co.uk/2/hi/health/1203140.stm